The efficiency of direct steam injection (DSI) at 105°C for 3 s to inactivate Mycobacterium avium subsp. paratuberculosis in milk at a pilot-plant scale was investigated. Milk samples were artificially contaminated with M. avium subsp. paratuberculosis and also with cow fecal material naturally infected with M. avium subsp. paratuberculosis. We also tested milk artificially contaminated with Mycobacterium smegmatis as a candidate surrogate to compare thermal inactivation between M. smegmatis and M. avium subsp. paratuberculosis. Following the DSI process, no viable M. avium subsp. paratuberculosis or M. smegmatis was recovered using culture methods for both strains. For pure M. avium subsp. paratuberculosis cultures, a minimum reduction of 5.6 log 10 was achieved with DSI, and a minimum reduction of 5.7 log 10 was found with M. smegmatis. The minimum log 10 reduction for wild-type M. avium subsp. paratuberculosis naturally present in feces was 3.3. In addition, 44 dairy and nondairy powdered infant formula (PIF) ingredients used during the manufacturing process of PIF were tested for an alternate source for M. avium subsp. paratuberculosis and were found to be negative by quantitative PCR (qPCR). In conclusion, the results obtained from this study indicate that a >7-fold-log 10 reduction of M. avium subsp. paratuberculosis in milk can be achieved with the applied DSI process.
M ycobacterium avium subsp. paratuberculosis is a well-known animal pathogen that causes Johne's disease (JD), also known as paratuberculosis, in cattle. JD has a global occurrence and is widely prevalent among dairy herds (1) . Besides the negative impact on animal health and welfare and being the cause of economic losses, e.g., due to reduced milk production, M. avium subsp. paratuberculosis has also been suggested to be the causative agent of Crohn's disease in humans (2) . It has been proposed that milk contaminated with M. avium subsp. paratuberculosis might act as a source of human exposure (3) .
Infected animals may shed M. avium subsp. paratuberculosis in milk and feces, resulting in direct or indirect contamination of milk (4) . M. avium subsp. paratuberculosis levels in raw milk from individual cows range between 2 and 8 CFU/50 ml of milk (5) , and in a Canadian study, levels of 1 to 24 CFU/ml were reported (6) . Through simulated modeling, M. avium subsp. paratuberculosis levels in raw bulk tank milk (BTM) obtained from farms with good hygienic practices were estimated to fall between 0.54 and 7.03 CFU/ml (7) . A recent quantitative risk assessment study of BTM supplied to three Italian dairy plants collected from 569 farms estimated M. avium subsp. paratuberculosis levels at 1.2 to 2.8 CFU/ml at the 95th percentile of the distribution (8) .
In general, thermal treatment (e.g., high temperature, short holding time [HTST] [72°C, 15 s] pasteurization) is applied to ensure the microbiological safety of BTM. Several studies have investigated laboratory-scale M. avium subsp. paratuberculosis inactivation following low temperature, long holding time (LTLT) (63°C, 30 min) and HTST pasteurization conditions and have reported reduction levels ranging from a minimum of Ͻ2 log 10 to a maximum of Ͼ6 log 10 units (9) . HTST pasteurization under industrial turbulent-flow conditions has been found to provide between 4-and 7-log 10 reductions of M. avium subsp. paratuberculosis in milk (4, (10) (11) (12) (13) (14) (15) (16) (17) (18) . However, some authors have reported the survival of M. avium subsp. paratuberculosis following these heat treatment conditions (4, 13, 14, 16, 17) . Disparities seen in the reduction levels can be attributed mostly to the differences in experimental conditions, as were previously reported (19) (20) (21) .
Pertinently, most of these studies have used laboratory-grown strains of M. avium subsp. paratuberculosis to spike the milk samples (4, 10, (13) (14) (15) (16) (17) . Such M. avium subsp. paratuberculosis strains may have developed altered heat resistance and/or clumping characteristics due to their adaptation to laboratory growth conditions (11) . As reported in these M. avium subsp. paratuberculosis inactivation studies, milk spiked with fecal material naturally infected with wild-type M. avium subsp. paratuberculosis more closely simulates real-life contamination. Therefore, inactivation parameters derived from such studies may be more reliable than those not using fecal material (11, 18) .
M. avium subsp. paratuberculosis detection and enumeration are challenging, particularly due to the long incubation periods required for its growth. In a study on the heat sensitivity of M. avium subsp. paratuberculosis during pasteurization, the authors also included a strain of Mycobacterium smegmatis, which has an advantageous ability to grow faster in culture (12) . The determined decimal reduction time at 65°C (D 65°C ) for this strain was 25 s, whereas the D 65°C value for M. avium subsp. paratuberculosis strain ATCC 19698 was 20 s. As the M. smegmatis strain was slightly more heat resistant and displays similar clumping physiology to that of M. avium subsp. paratuberculosis (12) , this microorganism was considered a candidate surrogate for M. avium subsp. paratuberculosis.
Milk is heat processed using indirect or direct heating systems. Commercial dairies typically use tubular heat exchangers to indirectly heat the milk to reach HTST pasteurization (72°C, 15 s) or higher time-temperature conditions. Direct heat treatment of milk is achieved either by direct steam injection (DSI) or direct steam infusion, in which steam is in direct contact with the matrix. This is followed by extraction of the added steam and cooling off of the matrix (22) . The application of DSI to heat treat milk during the manufacturing process of products, such as infant formula, is not uncommon. In the dairy industry, heat processes applied to treat milk have safety margins added to the defined processing parameters (e.g., HTST) to ensure the microbiological safety of the product. For example, temperatures between 105°C and 125°C for 5 s may be employed, depending on the product characteristics and processing capabilities (23) .
In spite of the low M. avium subsp. paratuberculosis levels reported in BTM and 4-to 7-log 10 reductions achieved following HTST pasteurization, the presence of viable M. avium subsp. paratuberculosis has been reported in retail pasteurized milk (17, 24, 25) , cheese products (26) , and powdered infant formula (PIF) (27) . Considering these reports, studies on the efficacy of the DSI process for M. avium subsp. paratuberculosis inactivation warrants further investigation. In this report, we present the thermal inactivation of M. avium subsp. paratuberculosis and M. smegmatis by DSI. To our knowledge, this is the first M. avium subsp. paratuberculosis inactivation study that has been carried out using DSI. For the trials, we evaluated the comparative inactivation of M. avium subsp. paratuberculosis and M. smegmatis in milk artificially contaminated with pure culture and also with cow fecal material naturally infected with M. avium subsp. paratuberculosis at 105°C for 3 s. Given the reports of M. avium subsp. paratuberculosis in thermally processed commercial products, including PIF, and the previously reported presence of M. avium subsp. paratuberculosis in BTM, it was also considered pertinent to assess if raw milk samples used for such products harbor M. avium subsp. paratuberculosis or if other ingredients added during PIF production might act as a source of M. avium subsp. paratuberculosis. Therefore, in this study, BTM, dairy and nondairy ingredients were also screened for the presence of M. avium subsp. paratuberculosis.
MATERIALS AND METHODS
Screening of bulk tank milk and PIF ingredients. Samples from 48 different Swiss dairy herds were screened for the presence of M. avium subsp. paratuberculosis by quantitative PCR (qPCR), as described below. Fortyfour dairy and nondairy-based PIF ingredients were also screened for the presence of M. avium subsp. paratuberculosis by qPCR. For powder ingredient samples, 5 g was resuspended in 45 ml of 37°C preheated sterile water and processed afterwards as liquid ingredient samples.
Bacterial strains and culture conditions. Each freeze-dried M. avium subsp. paratuberculosis and M. smegmatis strain was suspended in 1 ml of Middlebrook 7H9 broth supplemented with 10% oleic acid-albumin-dextrose-catalase (OADC) (Becton Dickinson, NJ, USA) and 2 g/ml mycobactin J (Synbiotics Europe SAS, Lyon, France) and transferred into 4 ml of Middlebrook 7H9 broth supplemented with 10% OADC and 2 g/ml mycobactin J. M. avium subsp. paratuberculosis culture was streaked onto Herrold's egg yolk medium (HEYM) agar plates and incubated for 6 weeks at 37°C, whereas M. smegmatis was streaked on HEYM agar supplemented with 10% OADC and incubated at 37°C for 3 days. Following incubation, colonies were resuspended in a cryopreservation system tube (Technical Service Consultants Ltd., Lancashire, United Kingdom) and stored at Ϫ80°C. M. avium subsp. paratuberculosis strains were confirmed by qPCR prior to the cryopreservation. M. avium subsp. paratuberculosis strains were always grown from the working stock to reach the stationary phase, as described elsewhere (29) , before use in the spiking studies. Briefly, Middlebrook 7H9 broth supplemented with 10% OADC and 2 g/ml mycobactin J inoculated with M. avium subsp. paratuberculosis from the working stock were incubated in a shaker (150 rpm) incubator for 6 weeks at 37°C and grown to stationary phase. Similarly, M. smegmatis strains were grown in a shaker (150 rpm) incubator for 3 days at 37°C to stationary phase in Middlebrook 7H9 broth supplemented with 10% OADC.
Evaluation of milk quality. Ultrahigh-temperature (UHT) whole milk, UHT skimmed milk, and raw milk were used for the spiking experiments. For each batch of milk used, its quality was assessed by enumerating the background microflora. Mesophilic and thermophilic bacteria were enumerated on plate count agar (PCA; Oxoid Ltd., Basingstoke, United Kingdom) and incubated at 30°C for 3 days and at 55°C for 2 days, respectively. Mesophilic aerobic spores were enumerated on PCA containing starch incubated at 30°C for 3 days. For spore enumeration, vegetative bacteria were inactivated by heating the samples at 80°C for 10 min before plating. All microbiological analyses were done with triplicate samples. Prior to spiking, milk samples were also prescreened for the presence of M. avium subsp. paratuberculosis by culture and qPCR, as described below.
Cow feces suspension preparation. Frozen (Ϫ80°C) cow feces naturally infected with M. avium subsp. paratuberculosis was thawed overnight at 4°C and then diluted at a 1:1 ratio using phosphate-buffered saline (PBS). The diluted feces was filtered through three layers of hairnets in order to remove coarse particles and then was centrifuged at 2,500 ϫ g for 15 min in 50-ml centrifuge tubes. The supernatant was discarded, and the pellets containing concentrated M. avium subsp. paratuberculosis cells were stored at Ϫ80°C before being used in the DSI experiments.
Spiking of milk samples. Retail UHT skimmed and whole milk and raw milk sourced from a local Swiss dairy were used for spiking. For each DSI trial, 150 ml of broth culture was centrifuged at 2,500 ϫ g for 15 min, and the supernatant was removed. The pellet was resuspended in 150 ml of milk (UHT skimmed milk, UHT whole milk, or raw whole milk). Cells of M. avium subsp. paratuberculosis or M. smegmatis were declumped by ultrasound sonication (7 min on sweep mode in water maintained at Ͻ10°C [Transsonic TI-H5 MF; Elma, Singen, Germany]). The sonicated inoculum was subsequently transferred to 1,350 ml of each milk type and shaken vigorously. For the feces inoculum naturally infected with M. avium subsp. paratuberculosis, 8 pellet tubes were thawed overnight at 4°C. Each pellet was then resuspended in 50 ml of each milk (UHT skimmed milk, UHT whole milk, and raw whole milk), and all of the 8 pellet tubes were subsequently combined. The resulting 400-ml suspension was subjected to ultrasound sonication, as described previously. The sonicated inoculum was transferred to 1,100 ml of milk (UHT skimmed milk, UHT whole milk, or raw whole milk, respectively) and mixed thoroughly to ensure homogenous suspension of the cells. The initial inoculation level aimed to reach a minimum of 10 5 CFU/ml for both M. avium subsp. paratuberculosis and M. smegmatis. Spiking levels were determined by using 50 ml and 1 ml of the inoculated samples, respectively. Enumeration was commenced immediately after spiking of the samples without any time delay.
DSI treatment of spiked milk. Inactivation studies on M. avium subsp. paratuberculosis and M. smegmatis were carried out using the Armfield FT74DI direct steam injection UHT system coupled with the Armfield FT105 Asepto-Fill filler-closer unit equipment (Armfield Limited, Hampshire, England) ( Fig. 1) . Time, temperature, and pressure readings were monitored at several points and recorded every 10 s during the trials using the Armfield FT74DI-90IFD-USB data logging system. The critical temperature measurement recording points in the DSI equipment are indicated in Fig. 1 .
Three DSI trials were performed for each spiked milk matrix-microorganism combination, corresponding to 54 trials in total. The system was flushed and sterilized at 130°C for 20 min between each trial to avoid any carryover contamination. A flowchart shown in Fig. 2 provides an overview of the experimental setup.
DSI process description. The temperature of milk at the inlet of the DSI equipment was 19.3°C Ϯ 0.6°C (T1 in Fig. 1 ), and it was subsequently preheated to 79.1°C Ϯ 0.1°C (T2 in Fig. 1 ) before being injected with steam to reach 105°C (T3 in Fig. 1 ). Food-grade steam was injected using a nozzle at approximately 4 ϫ 10 5 Pa of pressure into the milk for its thermal treatment. A continuous sample flow rate of 9.3 liters/h was established to ensure a residence time of 3 s at 105°C Ϯ 0.6°C (T3 in Fig. 1 ). The milk temperature following the removal of the steam was found to be 77.6°C Ϯ 2.0°C (T4 in Fig. 1 ) before being cooled down using a tubular heat exchanger. After cooling, the milk was at the desired temperature of 30.3°C Ϯ 0.2°C (T5 in Fig. 1 ) before samples were collected for post-DSI M. avium subsp. paratuberculosis and M. smegmatis enumeration. In order to ensure that the product was processed at the set time/temperature, temperature balancing of each cycle was undertaken using mains water.
Sampling for M. avium subsp. paratuberculosis and M. smegmatis enumeration post-DSI. Each DSI trial lasted for approximately 10 min, in which 1.5 liters of spiked milk (UHT skimmed milk, UHT whole milk, or raw whole milk) was processed. Samples for post-DSI enumeration were collected at three different time points from the aseptic filling unit area (T5 in Fig. 1 ) over the duration of a single trial. This was done to verify the stability of the process, i.e., that there was not a smaller log 10 reduction at the beginning of the trial compared to the end. A total of five samples of 50 ml each were collected at 4th, 6th, and 8th min following the start of the trial to enumerate viable M. avium subsp. paratuberculosis and M. smegmatis. Samples were incubated overnight at 4°C to improve the recovery of sublethally injured bacterial cells before enumeration. In addition to the culture method, qPCR was also carried out on samples spiked with M. avium subsp. paratuberculosis.
M. avium subsp. paratuberculosis enumeration. To concentrate the M. avium subsp. paratuberculosis cells, 50-ml milk samples were centrifuged at 2,500 ϫ g for 15 min and the pellet resuspended in 5 ml of tryptone salt solution (TS) (8. Agar plates were sealed with DuraSeal laboratory sealing film (Diversified Biotech, MA, USA), incubated at 37°C for 7 to 8 weeks, and M. avium subsp. paratuberculosis colonies were enumerated, which were confirmed by their typical morphology.
A peptide magnetic separation (PMS) procedure described below was combined with the culture method to enumerate M. avium subsp. paratuberculosis from samples containing higher background microflora, i.e., all UHT milk spiked with feces and all raw milk. As the volume recovered after PMS was 1 ml, 333 l was used to determine the count of the undiluted sample, and the remaining volume was used to prepare a 10-fold dilution series. One hundred microliters of these inocula was then plated on HEYM with PANTA agar plates and sealed, as described above. The plates were incubated at 37°C for 11 to 15 weeks for samples inoculated with feces and 7 to 8 weeks for raw milk samples spiked with pure M. avium subsp. paratuberculosis strains prior to the enumeration of M. avium subsp. paratuberculosis colonies.
PMS. The magnetic MyOne tosylactivated Dynabeads (Life Technologies, Carlsbad, CA, USA) were separately coated with biotinylated-aMp3 peptide (NYVIHDVPRHPA) and biotinylated-aMptD peptide (GKNHH HQHHRPQ), as described by Foddai et al. (30) . Fifty milliliters of milk was centrifuged at 2,500 ϫ g for 15 min, and the supernatant containing the cream and whey fractions was discarded. The pellet with the M. avium subsp. paratuberculosis cells was then resuspended in 1 ml of PBS containing 0.05% Tween 20 (PBS-T20; Sigma, St. Louis, MO, USA) and subjected to PMS carried out with a mixture of 5 l of each of the peptide-coated magnetic beads prepared before using the environmental program of the Dynal BeadRetriever (Life Technologies), as described by Foddai et al. (30) . Briefly, the M. avium subsp. paratuberculosis cells, captured by the peptide-coated magnetic beads, were washed twice in 1 ml of PBS-T20 and resuspended in 1 ml of TS. A negative control of 1 ml of TS was included in each PMS run to verify the absence of cross-contamination of the samples.
M. avium subsp. paratuberculosis DNA extraction and detection by qPCR. qPCR was applied to amplify the M. avium subsp. paratuberculosisspecific IS900 and f57 sequences from BTM and PIF ingredient samples, as previously described (31) . The amplification reactions were performed in duplicate for each sample (Applied Biosystems 7500 Fast real-time PCR system).
The positive control consisted of M. avium subsp. paratuberculosis (1.06 ϫ 10 2 CFU/ml) spiked into each of the PIF ingredient samples. The negative control, consisting of sterile water, was also analyzed in each series. For the screening of BTM, a positive and negative control were included in each series of DNA extraction and qPCR.
Pre-and post-DSI treatment milk samples were also tested for M. avium subsp. paratuberculosis using qPCR. Briefly, 50 ml of milk was centrifuged at 2,500 ϫ g for 15 min. After centrifugation, the supernatant was discarded, and the pellet containing the M. avium subsp. paratuberculosis cells was resuspended in 10 ml of molecular-grade water. The Adiapure kit (bioMérieux, Marcy l'Etoile, France) was then used to extract M. avium subsp. paratuberculosis DNA, according to the manufacturer's instructions. To remove the PCR inhibitors, extracted DNA was purified using Illustra MicroSpin G-25 columns (GE Healthcare Life Sciences, Little Chalfont, United Kingdom), according to the procedure recommended by the manufacturer. A negative control was included for each series of DNA extraction and qPCR.
M. smegmatis enumeration. Spiked UHT skimmed-and whole-milk samples before and after DSI treatment were enumerated by plating 1 ml of undiluted sample and 100 l of 10-fold serial dilutions on Middlebrook 7H9 agar supplemented with 10% OADC, incubated at 37°C for 3 days, and M. smegmatis colonies were enumerated, which were confirmed by their morphology. Raw-milk samples were analyzed under the same conditions as those for UHT milk but with the addition of an antibiotic cocktail containing 50 IU of nystatin, 2 g of oxacillin, and 30 g of aztreonam (NOA) (Abtek Biologicals, Liverpool, United Kingdom) per milliliter of agar.
RESULTS

Screening of bulk tank milk and PIF ingredients.
All 48 bulk tank milk samples tested were negative for IS900 and f57 targets with the Adiapure-qPCR method. Additionally, all of the 44 dairy and nondairy ingredients that are used during the manufacture of dry dairy products, such as PIF, were found to be negative for the same M. avium subsp. paratuberculosis targets by qPCR. The results obtained from the control samples were as expected. All spiked raw milk and PIF ingredient control samples tested positive with qPCR, and no signal was obtained from the negative controls.
Raw and UHT milk quality. All batches were enumerated for mesophilic and thermophilic bacteria and mesophilic aerobic spores. As expected, all UHT milk had counts below the detection limit of 1 CFU/ml in all tests. Raw milk, on the other hand, had mesophilic counts in the order of 10 4 CFU/ml, thermophilic counts of Ͻ1 CFU/ml, and ca. 5 ϫ 10 2 CFU/ml of mesophilic spores. The presence of M. avium subsp. paratuberculosis in raw milk was evaluated by culture and qPCR, and all samples were found to be negative. DSI operation conditions. After each trial, the recorded measurements were scrutinized to confirm that the parameters were stable throughout the thermal treatments.
Inactivation of M. avium subsp. paratuberculosis. The actual counts obtained from the spiked samples were used to determine log 10 reductions following DSI. As outlined in Table 1 , the concentration of M. avium subsp. paratuberculosis in inoculated samples before thermal treatment varied between strains. Overall, M. avium subsp. paratuberculosis strain DSM 44133 had a higher initial concentration (1.2 ϫ 10 5 to 3.5 ϫ 10 6 CFU/ml) than that of strain DSM 44135 (2.5 ϫ 10 4 to 7.2 ϫ 10 5 CFU/ml) in all samples, whereas the M. avium subsp. paratuberculosis concentration in samples contaminated with feces naturally infected with M. avium subsp. paratuberculosis was lower (1.9 ϫ 10 2 to 5.7 ϫ 10 2 CFU/ ml). To maximize the chance of M. avium subsp. paratuberculosis recovery, samples of 50 ml were tested. Through this, it was theoretically possible to enumerate M. avium subsp. paratuberculosis cells at levels of Ͻ0.1 and 0.06 CFU/ml for the culture and PMS culture methods, respectively ( Table 1) . As all enumerations following the DSI treatment were below the detection limit for M. avium subsp. paratuberculosis for all samples taken at the 4th, 6th, and 8th min during the course of a DSI trial, the counts determined before thermal treatment were used to estimate the minimum reduction achieved. CFU/ml for strains DSM 43756, DSM 43469, and ATCC 700084, respectively. As with M. avium subsp. paratuberculosis, M. smegmatis strains were completely inactivated in the DSI process, i.e., levels were below the limit of detection. The log 10 reductions obtained for M. smegmatis strains ranged from 5.74 to 7.19, 7.50 to 7.97, and 7.53 to 7.70 for DSM 43756, DSM 43469, and ATCC 700084, respectively. Similar reduction levels were obtained with all M. smegmatis strains, as the initial contamination levels achieved were comparable to each other. In two of the thermal treatments, the initial numbers were Ͻ10 7 CFU/ml, which resulted in a minimum average log 10 reduction of 7.3 for all treatments (Table 2) .
DISCUSSION
Two approaches were used for the enumeration of M. avium subsp. paratuberculosis bacteria in spiked milk samples before and after DSI treatment. Pure cultures of M. avium subsp. paratuberculosis inoculated into milk containing low background flora, i.e., UHT skim and UHT whole milk, were enumerated by a direct culture method using sealed agar plates (29, 32) . As expected, M. avium subsp. paratuberculosis enumerations in these matrices were done without difficulty due to limited interference from the background flora. As a higher background microflora level was expected for raw milk spiked with M. avium subsp. paratuberculosis and for all matrices spiked with cow fecal material naturally infected with M. avium subsp. paratuberculosis, the PMS culture method was applied to avoid a negative impact on M. avium subsp. paratuberculosis recovery. The use of this PMS step (30) prior to M. avium subsp. paratuberculosis enumeration has been shown to reduce interference from the background flora in phagebased and qPCR assays (8, 33, 34) . Although M. avium subsp. paratuberculosis can withstand chemical decontamination procedures used for its recovery, some researchers have shown that it can result in a reduced recovery of M. avium subsp. paratuberculosis (35, 36) , especially when applied on stressed or damaged cells (37) . This has been suggested to result in an inaccurate estimation of M. avium subsp. paratuberculosis reduction levels, and few studies have therefore reported M. avium subsp. paratuberculosis inactivation rates, avoiding the use of a chemical decontamination step (4) . An antibiotic cocktail, PANTA, has been reported to successfully suppress the background flora during M. avium subsp. paratuberculosis enumeration (31) . The results obtained in this study indicate that PANTA did not adversely impact the enumeration of M. avium subsp. paratuberculosis bacteria inoculated in milk matrices, as the counts obtained with and without PANTA were not significantly different (average Ϯ SD, 0.07 Ϯ 0.25 CFU/ml; P ϭ 0.32, onesample t test). Therefore, the PMS step along with the use of PANTA provided a suitable alternative to the use of chemical decontamination for M. avium subsp. paratuberculosis enumeration, even in matrices in which high background flora levels were present.
To our knowledge, this is the first report on the efficacy of the thermal DSI process to inactivate M. avium subsp. paratuberculosis in milk. Attempts to source BTM containing M. avium subsp. paratuberculosis were unsuccessful, as all 48 samples tested negative for M. avium subsp. paratuberculosis by qPCR. Therefore, our experiments were limited to artificially contaminated milk samples. Although the approach of artificial contamination with pure culture has been used in several inactivation studies, inoculation of milk samples with wild-type M. avium subsp. paratuberculosis naturally present in fecal material was also carried out to closely mimic the natural contamination of milk.
M. avium subsp. paratuberculosis survivors were not recovered in any of the DSI trials. A minimum of 5-log 10 inactivation was obtained for all milk matrices examined and those samples artificially contaminated with M. avium subsp. paratuberculosis. For the samples spiked with feces, it was not possible to achieve the intended level of 10 5 CFU/ml due to the low level of M. avium subsp. paratuberculosis in the feces. This explains the lower reductions obtained for these samples (3.3 to 4.0 log 10 ). Inactivation of M. avium subsp. paratuberculosis under DSI conditions has not been evaluated before. However, with no viable cells detected, the inactivation obtained in our study is at the higher end, or higher than previous reports of 4-to 7-log 10 reductions obtained under pilot-scale or industrial HTST pasteurization conditions (12, 18) . Studies using naturally infected feces for inoculation have been able to achieve only low levels of initial contamination (1.4 ϫ 10 3 to 4.5 ϫ 10 3 CFU/ml) and have calculated a minimum of 4-log 10 reduction, with no survivors detected, confirming the results obtained in this study. It is of interest to note that no major differences in the reduction levels obtained were noticed despite the use of chemical decontamination step in the previous studies (11, 12, 18) , which has been suggested to overestimate the reduction levels (4) .
Although it is accepted that sufficient thermal inactivation is achieved under LTLT or HTST conditions (38) , some studies have isolated low numbers of viable M. avium subsp. paratuberculosis following pasteurization studies (4, 13, 14, 16, 17) . The reasons for these disparities have been discussed and are suggested to be due to cross-contamination in the laboratory, handling of the heattreated samples, leaking heat exchanger plates, or build-up of milk solids in the heat exchanger used for pasteurization (21) . It has also been suggested that clumping of M. avium subsp. paratuberculosis cells may influence the survival of M. avium subsp. paratuberculosis, as some cells in the clumps may be protected by surrounding cells (4, 13) , but this was not confirmed in a later study (10) . Although sporulation among mycobacteria, including M. avium subsp. paratuberculosis, has been proposed (39, 40) , this has been challenged (41) , and there are no further reports supporting the theory of spore formation in M. avium subsp. paratuberculosis.
Before the DSI process, the milk is preheated to 80°C, a temperature that in itself will inactivate several log units of M. avium subsp. paratuberculosis for 1 s (11). Therefore, it was not unexpected that no viable M. avium subsp. paratuberculosis or M. smegmatis was recovered after DSI in this study. It is plausible that reductions as high as 7.53 log obtained with DSM 44133 in UHT whole milk can also be achieved with other strains. Overall, M. avium subsp. paratuberculosis inactivation rates obtained in our studies using pure culture and wild-type M. avium subsp. paratuberculosis strains naturally present in fecal inoculum are comparable or might be even higher than the log 10 reduction levels previously reported using pilot-or industrial-scale HTST pas- teurization equipment. DSI can be used to heat treat the milk during the manufacturing process of dry dairy products, such as PIF. In DSI operations, the temperature changes of the product occur instantaneously, which is not the case with indirect heating systems, like plate heat or tubular heat exchangers (42) . This might therefore have contributed to the inactivation of M. avium subsp. paratuberculosis observed in this study. Spiked milk samples collected before and after the DSI process were analyzed by qPCR for the presence of M. avium subsp. paratuberculosis DNA (Table 1 ). The ⌬C T values, which are the differences between the average C T values obtained before and after each DSI treatment, ranged from 1.80 to 3.45, which correspond to approximately one log 10 difference in terms of the actual numbers of bacteria. ⌬C T values could not be determined for samples spiked with feces, as dilution was required to overcome PCR inhibition. Since no survivors were recovered following the DSI treatment by the culture method, the differences seen in the C T values can be explained by the fact that the M. avium subsp. paratuberculosis DNA was only mildly degraded at such high thermal treatments, resulting in higher C T values post-DSI. Our findings confirm previous reports in which it was shown that DNA can withstand thermal degradation to yield positive PCR results (43, 44) . More importantly, the qPCR signal obtained post-DSI may explain the higher M. avium subsp. paratuberculosis prevalence rate, which has been reported in a PCR-based survey of PIF (e.g., Hruska et al. [28] ) and highlights the caution that must be exercised to interpret positive qPCR results, especially when the product has been subjected to a thermal microbial/inactivation step.
For M. smegmatis, an average reduction of 7.3 log 10 was achieved. Overall, a greater log 10 reduction with M. smegmatis was observed, as higher spiking levels of the samples were consistently achievable, which was not the case with M. avium subsp. paratuberculosis. Previously, it was shown that M. smegmatis has a slightly higher D value than that of M. avium subsp. paratuberculosis (12) . As our study does not prove that M. smegmatis can act as a surrogate for M. avium subsp. paratuberculosis, additional heat resistance studies will be required to confirm the surrogate potential of M. smegmatis. Owing to the slow-growing nature of M. avium subsp. paratuberculosis and the analytical challenges experienced during its recovery and culture, it would be highly valuable to have a microorganism that can be used as a M. avium subsp. paratuberculosis surrogate, both in terms of physiology and for pilot-plant-scale trials. As M. smegmatis has only ever been used once in heat inactivation studies (12) , it was considered an opportunity to compare its thermal inactivation with M. avium subsp. paratuberculosis in this pilot-plant-scale DSI experiment.
It is well known that BTM may harbor M. avium subsp. paratuberculosis, and the prevalence of M. avium subsp. paratuberculosis-positive samples reported varies from 0% to 60% (45) . Recently, BTM M. avium subsp. paratuberculosis levels were estimated to be between 1.2 and 2.8 CFU/ml (8) . While a 2013 study reported similar levels (0.54 to 7.03 CFU/ml) in most of the cases, they predicted that concentrations of up to 10 4 CFU/ml can occur, although rarely, in a worst-case scenario of fecal contamination of milk (7) . In this study, we used qPCR to test 48 individual raw bulk tank milk samples obtained from farmers in central Switzerland and found all of them to be negative for M. avium subsp. paratuberculosis. Although we screened only a limited number of BTM samples, the negative results obtained confirmed the low levels of M. avium subsp. paratuberculosis reported in BTM. These negative results, along with the reductions obtained in our M. avium subsp. paratuberculosis inactivation trials, indicates that it is highly unlikely that M. avium subsp. paratuberculosis survivors will be obtained following DSI treatment of milk.
In light of our DSI inactivation findings, the recent reports of M. avium subsp. paratuberculosis detection by phage and culture assay in PIF (27) are difficult to explain. We also tested 44 dairy and nondairy-based ingredients added to PIF (e.g., whey protein, lactose, and maltodextrin) to identify any potential alternate source of M. avium subsp. paratuberculosis but found them all to be negative by qPCR, with a limit of detection (LOD) of 14 and 130 PFU/50 ml for the IS900 and f57 targets, respectively, in PIF (our unpublished data). The majority of these ingredients themselves will have been subjected to thermal processing steps designed to inactivate vegetative cells and will constitute minor ingredients in PIF. Therefore, their potential contribution to any possible M. avium subsp. paratuberculosis presence in PIF would be considered minimal. Robust analytical methods have a key role to play in determining the presence or levels of M. avium subsp. paratuberculosis present in dairy matrices. As has been demonstrated here, qPCR-positive results from thermally processed products require very careful interpretation. While it is understood that culture methods are notoriously difficult for M. avium subsp. paratuberculosis, other nonculture-based methods will require similar scrutiny to ascertain their reproducibility and repeatability before drawing conclusions on the recovery of viable M. avium subsp. paratuberculosis from such products. It would be valuable if reports on the detection of M. avium subsp. paratuberculosis from pasteurized and heat-treated dairy products also attempt to further characterize the recovered isolates by, for example, heat resistance studies and whole-genome sequencing to gain further insight into this issue.
